T1	PROC 46 71	Estudio fase 1/2, abierto
T2	CHEM 76 85	Nivolumab
#1	AnnotatorNotes T2	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T3	PROC 89 100	monoterapia
#2	AnnotatorNotes T3	C4763675; Single Agent Therapy; Therapeutic or Preventive Procedure
T4	CHEM 103 112	Nivolumab
#3	AnnotatorNotes T4	C3657270; nivolumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T5	CHEM 127 137	ipilimumab
#4	AnnotatorNotes T5	C1367202; ipilimumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T6	DISO 153 168	tumores sólidos
#5	AnnotatorNotes T6	C0280100; Solid Neoplasm; Neoplastic Process
T7	DISO 217 232	Tumores sólidos
#6	AnnotatorNotes T7	C0280100; Solid Neoplasm; Neoplastic Process
T8	DISO 262 292	Cáncer de mama triple negativo
#7	AnnotatorNotes T8	C3539878; Triple Negative Breast Neoplasms; Neoplastic Process
T9	DISO 297 312	Cáncer gástrico
#8	AnnotatorNotes T9	C0024623; Malignant neoplasm of stomach; Neoplastic Process
T10	DISO 317 335	Cáncer pancreático
#9	AnnotatorNotes T10	C0281361; Adenocarcinoma of pancreas; Neoplastic Process | C0346647; Malignant neoplasm of pancreas; Neoplastic Process
T11	DISO 340 368	Cáncer microcítico de pulmón
T12	ANAT 945 951	vejiga
#10	AnnotatorNotes T12	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T13	ANAT 362 368	pulmón
#11	AnnotatorNotes T13	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T14	DISO 372 388	Cáncer de vejiga
#12	AnnotatorNotes T14	C0005684; Malignant neoplasm of urinary bladder; Neoplastic Process
T15	DISO 393 409	Cáncer de ovario
#13	AnnotatorNotes T15	C1140680; Malignant neoplasm of ovary; Neoplastic Process
T16	DISO 436 451	Tumores sólidos
#14	AnnotatorNotes T16	C0280100; Solid Neoplasm; Neoplastic Process
T17	DISO 481 511	Cáncer de mama triple negativo
#15	AnnotatorNotes T17	C3539878; Triple Negative Breast Neoplasms; Neoplastic Process
T18	DISO 522 537	Cáncer gástrico
#16	AnnotatorNotes T18	C0024623; Malignant neoplasm of stomach; Neoplastic Process
T19	DISO 539 541	CG
T20	DISO 546 564	Cáncer pancreático
#17	AnnotatorNotes T20	C0281361; Adenocarcinoma of pancreas; Neoplastic Process | C0346647; Malignant neoplasm of pancreas; Neoplastic Process
T21	DISO 575 603	Cáncer microcítico de pulmón
T22	DISO 513 517	CMTN
T23	ANAT 597 603	pulmón
#18	AnnotatorNotes T23	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T24	DISO 605 608	CMP
T25	DISO 614 630	Cáncer de vejiga
#19	AnnotatorNotes T25	C0005684; Malignant neoplasm of urinary bladder; Neoplastic Process
T26	DISO 640 656	Cáncer de ovario
#20	AnnotatorNotes T26	C1140680; Malignant neoplasm of ovary; Neoplastic Process
T27	DISO 566 570	CPan
T28	DISO 702 712	enfermedad
#21	AnnotatorNotes T28	C0012634; Disease; Disease or Syndrome
T29	DISO 799 808	tumorales
#22	AnnotatorNotes T29	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T30	DISO 812 842	Cáncer de mama triple negativo
#23	AnnotatorNotes T30	C3539878; Triple Negative Breast Neoplasms; Neoplastic Process
T31	DISO 845 860	Cáncer gástrico
#24	AnnotatorNotes T31	C0024623; Malignant neoplasm of stomach; Neoplastic Process
T32	DISO 863 881	Cáncer pancreático
#25	AnnotatorNotes T32	C0281361; Adenocarcinoma of pancreas; Neoplastic Process | C0346647; Malignant neoplasm of pancreas; Neoplastic Process
T33	DISO 884 912	Cáncer microcítico de pulmón
T34	ANAT 906 912	pulmón
#26	AnnotatorNotes T34	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T35	DISO 915 931	Cáncer de ovario
#27	AnnotatorNotes T35	C1140680; Malignant neoplasm of ovary; Neoplastic Process
T36	DISO 935 951	Cáncer de vejiga
#28	AnnotatorNotes T36	C0005684; Malignant neoplasm of urinary bladder; Neoplastic Process
T37	DISO 979 997	enfermedad medible
#29	AnnotatorNotes T37	C1513041; Measurable Disease; Disease or Syndrome
T38	DISO 1101 1122	Metástasis cerebrales
#30	AnnotatorNotes T38	C0220650; Metastatic malignant neoplasm to brain; Neoplastic Process | C0555278; Cerebral metastasis; Neoplastic Process
T39	DISO 1133 1158	metástasis leptomeníngeas
#31	AnnotatorNotes T39	C1704231; Metastatic Malignant Neoplasm to the Leptomeninges; Neoplastic Process
T40	DISO 1175 1201	enfermedad autoinmunitaria
#32	AnnotatorNotes T40	C0004364; Autoimmune Diseases; Disease or Syndrome
T41	PROC 1269 1290	tratamiento sistémico
T42	CHEM 1295 1311	corticosteroides
#33	AnnotatorNotes T42	C0001617; Adrenal Cortex Hormones; Hormone · Organic Chemical · Pharmacologic Substance
T43	CHEM 1324 1334	prednisona
#34	AnnotatorNotes T43	C0032952; prednisone; Hormone · Organic Chemical · Pharmacologic Substance
T44	CHEM 1365 1394	medicamentos inmunosupresores
T45	CHEM 1449 1456	fármaco
#35	AnnotatorNotes T45	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T46	DISO 632 635	Cve
T47	PROC 1475 1486	tratamiento
#36	AnnotatorNotes T47	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T48	ANAT 1564 1576	linfocitos T
#37	AnnotatorNotes T48	C0039194; T-Lymphocyte; Cell
T49	PROC 1579 1631	tratamiento dirigido a las vías del punto de control
#38	AnnotatorNotes T49	C4733472; Immune checkpoint inhibitor therapy; Therapeutic or Preventive Procedure
T50	CHEM 1638 1659	anticuerpos anti-PD-1
T51	CHEM 1685 1695	anti-CD137
T52	CHEM 1661 1671	anti-PD-L1
T53	CHEM 1673 1683	anti-PD-L2
T54	CHEM 1698 1709	anti-CTLA-4
T55	CHEM 1720 1730	ipilimumab
#39	AnnotatorNotes T55	C1367202; ipilimumab; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
T56	CHEM 1740 1797	medicamentos dirigidos específicamente a los linfocitos T
#40	AnnotatorNotes T56	C3192215; Selective T Cell Costimulation Blocker; Pharmacologic Substance (?)
T57	ANAT 1785 1797	linfocitos T
#41	AnnotatorNotes T57	C0039194; T-Lymphocyte; Cell
T58	DISO 181 193	metastásicos
#42	AnnotatorNotes T58	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T59	DISO 245 257	metastásicos
#43	AnnotatorNotes T59	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T60	ANAT 272 276	mama
#44	AnnotatorNotes T60	C0006141; Breast; Body Part, Organ, or Organ Component | C1268990; Entire breast; Body Part, Organ, or Organ Component
T61	ANAT 304 312	gástrico
#45	AnnotatorNotes T61	C0038351; Stomach; Body Part, Organ, or Organ Component | C1278920; Entire stomach; Body Part, Organ, or Organ Component | C3714551; Stomach structure; Body Part, Organ, or Organ Component
T62	ANAT 324 335	pancreático
#46	AnnotatorNotes T62	C0030274; Pancreas; Body Part, Organ, or Organ Component | C1278931; Entire pancreas; Body Part, Organ, or Organ Component
T63	ANAT 347 358	microcítico
#47	AnnotatorNotes T63	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T64	ANAT 382 388	vejiga
#48	AnnotatorNotes T64	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T65	ANAT 403 409	ovario
#49	AnnotatorNotes T65	C0029939; Ovary; Body Part, Organ, or Organ Component | C1278992; Entire ovary; Body Part, Organ, or Organ Component
T66	DISO 464 476	metastásicos
#50	AnnotatorNotes T66	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T67	ANAT 491 495	mama
#51	AnnotatorNotes T67	C0006141; Breast; Body Part, Organ, or Organ Component | C1268990; Entire breast; Body Part, Organ, or Organ Component
T68	ANAT 529 537	gástrico
#52	AnnotatorNotes T68	C0038351; Stomach; Body Part, Organ, or Organ Component | C1278920; Entire stomach; Body Part, Organ, or Organ Component | C3714551; Stomach structure; Body Part, Organ, or Organ Component
T69	ANAT 553 564	pancreático
#53	AnnotatorNotes T69	C0030274; Pancreas; Body Part, Organ, or Organ Component | C1278931; Entire pancreas; Body Part, Organ, or Organ Component
T70	ANAT 582 593	microcítico
#54	AnnotatorNotes T70	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T71	ANAT 624 630	vejiga
#55	AnnotatorNotes T71	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T72	ANAT 650 656	ovario
#56	AnnotatorNotes T72	C0029939; Ovary; Body Part, Organ, or Organ Component | C1278992; Entire ovary; Body Part, Organ, or Organ Component
T73	DISO 658 660	CO
T74	DISO 735 746	metastásica
#57	AnnotatorNotes T74	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T75	ANAT 822 826	mama
#58	AnnotatorNotes T75	C0006141; Breast; Body Part, Organ, or Organ Component | C1268990; Entire breast; Body Part, Organ, or Organ Component
T76	ANAT 852 860	gástrico
#59	AnnotatorNotes T76	C0038351; Stomach; Body Part, Organ, or Organ Component | C1278920; Entire stomach; Body Part, Organ, or Organ Component | C3714551; Stomach structure; Body Part, Organ, or Organ Component
T77	ANAT 870 881	pancreático
#60	AnnotatorNotes T77	C0030274; Pancreas; Body Part, Organ, or Organ Component | C1278931; Entire pancreas; Body Part, Organ, or Organ Component
T78	ANAT 891 902	microcítico
#61	AnnotatorNotes T78	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T79	ANAT 925 931	ovario
#62	AnnotatorNotes T79	C0029939; Ovary; Body Part, Organ, or Organ Component | C1278992; Entire ovary; Body Part, Organ, or Organ Component
T80	ANAT 1112 1122	cerebrales
#63	AnnotatorNotes T80	C0242202; Cerebrum; Body Part, Organ, or Organ Component | C1269537; Entire brain; Body Part, Organ, or Organ Component | C1280654; Entire cerebrum; Body Part, Organ, or Organ Component
T81	ANAT 1144 1158	leptomeníngeas
#64	AnnotatorNotes T81	C0228126; Leptomeninges; Body Part, Organ, or Organ Component | C1284563; Entire leptomeninges; Body Part, Organ, or Organ Component
T82	PROC 1430 1456	administración del fármaco
#65	AnnotatorNotes T82	C3469597; Administration of medication; Therapeutic or Preventive Procedure
T83	CHEM 1498 1519	vacunas antitumorales
T84	Date 13 17	2013
T85	LIVB 141 148	sujetos
#66	AnnotatorNotes T85	C0681850; Study Subject; Group
T88	LIVB 690 697	Sujetos
#67	AnnotatorNotes T88	C0681850; Study Subject; Group
T90	LIVB 959 966	sujetos
#68	AnnotatorNotes T90	C0681850; Study Subject; Group
T92	LIVB 1163 1170	Sujetos
#69	AnnotatorNotes T92	C0681850; Study Subject; Group
T93	Spec_cue 1221 1231	sospechada
T94	LIVB 1235 1242	Sujetos
#70	AnnotatorNotes T94	C0681850; Study Subject; Group
T95	Dose 1313 1320	> 10 mg
T96	Frequency 1335 1341	al día
T97	Duration 1405 1416	los 14 días
T86	PHYS 1546 1576	coestimulación de linfocitos T
#71	AnnotatorNotes T86	C1622572; T cell costimulation; Cell Function
T87	PROC 1000 1016	Estado funcional
#72	AnnotatorNotes T87	C4525818; Clinical Performance Status; Health Care Activity | C3694602; functional status of patient; Therapeutic or Preventive Procedure
T89	PROC 758 774	histológicamente
#73	AnnotatorNotes T89	C0344441; Histology Procedure; Laboratory Procedure
A1	Assertion T40 Speculated
A2	Assertion T83 Contraindicated
A3	Status T47 History_of
A4	Assertion T47 Contraindicated
A5	Assertion T49 Contraindicated
A6	Assertion T50 Contraindicated
A7	Assertion T52 Contraindicated
A8	Assertion T53 Contraindicated
A12	Status T83 History_of
A9	Assertion T51 Contraindicated
A10	Assertion T54 Contraindicated
A11	Assertion T55 Contraindicated
A13	Assertion T56 Contraindicated
A14	Status T40 History_of
#74	AnnotatorNotes T1	C1519043; Phase I/II Trial; Research Activity + C1709323; Open Label Study; Research Activity 
#75	AnnotatorNotes T22	C3539878; Triple Negative Breast Neoplasms; Neoplastic Process
#76	AnnotatorNotes T19	C0024623; Malignant neoplasm of stomach; Neoplastic Process
#77	AnnotatorNotes T27	C0281361; Adenocarcinoma of pancreas; Neoplastic Process | C0346647; Malignant neoplasm of pancreas; Neoplastic Process
#78	AnnotatorNotes T46	C0005684; Malignant neoplasm of urinary bladder; Neoplastic Process
#79	AnnotatorNotes T73	C1140680; Malignant neoplasm of ovary; Neoplastic Process
#80	AnnotatorNotes T44	C0021081; Immunosuppressive Agents; Immunologic Factor · Pharmacologic Substance
#81	AnnotatorNotes T50	C4289971; Anti-PD-L1 Monoclonal Antibody; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
#82	AnnotatorNotes T52	C4289971; Anti-PD-L1 Monoclonal Antibody; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
#83	AnnotatorNotes T51	C4732974; Anti-CD137 Monoclonal Antibody; Amino Acid, Peptide, or Protein · Immunologic Factor · Pharmacologic Substance
#84	AnnotatorNotes T54	C4289973; Anti-CTLA-4 Monoclonal Antibody; Amino Acid, Peptide, or Protein 
R1	Used_for Arg1:T2 Arg2:T3	
R2	Combined_with Arg1:T4 Arg2:T5	
R3	Experiences Arg1:T85 Arg2:T2	
R4	Experiences Arg1:T85 Arg2:T4	
R5	Experiences Arg1:T85 Arg2:T6	
R6	Experiences Arg1:T85 Arg2:T58	
R7	Before Arg1:T6 Arg2:T58	
T91	Quantifier_or_Qualifier 169 178	avanzados
#85	AnnotatorNotes T91	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R8	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T91	
T98	Quantifier_or_Qualifier 233 242	avanzados
#86	AnnotatorNotes T98	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R9	Has_Quantifier_or_Qualifier Arg1:T7 Arg2:T98	
R10	Before Arg1:T7 Arg2:T59	
R11	Location_of Arg1:T60 Arg2:T8	
R12	Location_of Arg1:T61 Arg2:T9	
R13	Location_of Arg1:T62 Arg2:T10	
R14	Location_of Arg1:T63 Arg2:T11	
R15	Location_of Arg1:T13 Arg2:T11	
#87	AnnotatorNotes T11	C0149925; Small cell carcinoma of lung; Neoplastic Process
R16	Location_of Arg1:T64 Arg2:T14	
R17	Location_of Arg1:T65 Arg2:T15	
T99	Quantifier_or_Qualifier 452 461	avanzados
#88	AnnotatorNotes T99	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R18	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T99	
R19	Before Arg1:T16 Arg2:T66	
R20	Location_of Arg1:T67 Arg2:T17	
R21	Location_of Arg1:T67 Arg2:T22	
R22	Location_of Arg1:T68 Arg2:T18	
R23	Location_of Arg1:T68 Arg2:T19	
R24	Location_of Arg1:T69 Arg2:T20	
R25	Location_of Arg1:T69 Arg2:T27	
R26	Location_of Arg1:T23 Arg2:T24	
R27	Location_of Arg1:T70 Arg2:T21	
R28	Location_of Arg1:T70 Arg2:T24	
#89	AnnotatorNotes T24	C0149925; Small cell carcinoma of lung; Neoplastic Process
#90	AnnotatorNotes T21	C0149925; Small cell carcinoma of lung; Neoplastic Process
R29	Location_of Arg1:T71 Arg2:T25	
R30	Location_of Arg1:T71 Arg2:T46	
R31	Location_of Arg1:T72 Arg2:T73	
R32	Location_of Arg1:T72 Arg2:T26	
T100	Quantifier_or_Qualifier 713 732	localmente avanzada
R33	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T100	
R34	Experiences Arg1:T88 Arg2:T28	
R35	Experiences Arg1:T88 Arg2:T74	
R36	Before Arg1:T28 Arg2:T74	
R40	Location_of Arg1:T75 Arg2:T30	
R41	Location_of Arg1:T76 Arg2:T31	
R42	Location_of Arg1:T77 Arg2:T32	
R43	Location_of Arg1:T78 Arg2:T33	
R44	Location_of Arg1:T34 Arg2:T33	
R45	Location_of Arg1:T79 Arg2:T35	
R46	Location_of Arg1:T12 Arg2:T36	
R47	Experiences Arg1:T90 Arg2:T37	
T101	CONC 1021 1055	Eastern Cooperative Oncology Group
#91	AnnotatorNotes T101	C1520224; ECOG performance status; Intellectual Product
R48	Used_for Arg1:T101 Arg2:T87	
T102	CONC 1057 1061	ECOG
#92	AnnotatorNotes T102	C1520224; ECOG performance status; Intellectual Product
R49	Used_for Arg1:T102 Arg2:T87	
T103	Result_or_Value 1066 1071	0 ó 1
R50	Has_Result_or_Value Arg1:T102 Arg2:T103	
R51	Has_Result_or_Value Arg1:T101 Arg2:T103	
R52	Location_of Arg1:T80 Arg2:T38	
R53	Location_of Arg1:T81 Arg2:T39	
T104	Quantifier_or_Qualifier 1123 1130	activas
#93	AnnotatorNotes T104	C0679217; Active State; Idea or Concept
R54	Has_Quantifier_or_Qualifier Arg1:T38 Arg2:T104	
T105	Quantifier_or_Qualifier 1202 1208	activa
#94	AnnotatorNotes T105	C0679217; Active State; Idea or Concept
R55	Has_Quantifier_or_Qualifier Arg1:T40 Arg2:T105	
R56	Experiences Arg1:T92 Arg2:T40	
R57	Speculation Arg1:T93 Arg2:T40	
R58	Experiences Arg1:T94 Arg2:T41	
R59	Used_for Arg1:T42 Arg2:T41	
R60	Has_Dose_or_Strength Arg1:T43 Arg2:T95	
R61	Has_Frequency Arg1:T43 Arg2:T96	
R62	Used_for Arg1:T43 Arg2:T41	
R63	Used_for Arg1:T44 Arg2:T41	
R64	Before Arg1:T44 Arg2:T82	
R65	Used_for Arg1:T45 Arg2:T82	
R66	Overlap Arg1:T44 Arg2:T97	
R67	Experiences Arg1:T94 Arg2:T44	
#95	AnnotatorNotes T33	C0149925; Small cell carcinoma of lung; Neoplastic Process
T106	CONC 1321 1334;1344 1355	de prednisona equivalente
R69	Used_for Arg1:T83 Arg2:T47	
R70	Location_of Arg1:T48 Arg2:T86	
#96	AnnotatorNotes T83	C0597031; neoplasm/cancer vaccine; Immunologic Factor · Pharmacologic Substance | C0376659; Cancer Vaccines; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Immunologic Factor
T107	Quantifier_or_Qualifier 1520 1534	experimentales
A15	Status T107 History_of
A16	Assertion T107 Contraindicated
#97	AnnotatorNotes T107	C1517586; Investigational; Qualitative Concept
R71	Has_Quantifier_or_Qualifier Arg1:T83 Arg2:T107	
R72	Used_for Arg1:T50 Arg2:T49	
R73	Used_for Arg1:T52 Arg2:T49	
R74	Used_for Arg1:T53 Arg2:T49	
R75	Used_for Arg1:T51 Arg2:T49	
R76	Used_for Arg1:T55 Arg2:T49	
R77	Used_for Arg1:T56 Arg2:T49	
R78	Experiences Arg1:T88 Arg2:T29	
R79	Experiences Arg1:T88 Arg2:T89	
R80	Experiences Arg1:T94 Arg2:T82	
R81	Overlap Arg1:T41 Arg2:T97	
R82	Before Arg1:T41 Arg2:T82	
#98	AnnotatorNotes T41	C1515119; Systemic Therapy; Therapeutic or Preventive Procedure
R83	Location_of Arg1:T23 Arg2:T21	
R37	Overlap Arg1:T43 Arg2:T97	
R38	Before Arg1:T43 Arg2:T82	
A17	Experiencer T85 Patient
A18	Experiencer T88 Patient
A19	Experiencer T90 Patient
A20	Experiencer T92 Patient
A21	Experiencer T94 Patient
